China's PatPat gets $160m in Series D extension
PatPat, a Chinese-founded children’s wear brand, has raised $160 million from Softbank Vision Fund in a Series D round extension.
It comes one month after PatPat confirmed raising $510 million across its Series C and D rounds. The sizes of the individual rounds were not disclosed, although they are said to have established the company’s...
Co-Stone leads $43m round for China biosynthesis player
Co-Stone Capital Management has led a CNY 300m (USD 43m) Series B round for Readline, a Shenzhen-based company that specialises in synthetic biology.
Australia’s Heal Partners closes debut fund on $137m
Australia’s Heal Partners, a health, education, and lifestyle-focused venture capital firm, has closed its first fund on AUD 200m (USD 137m). The target was AUD 100m.
US regulator gets access to Chinese audits
The threat of delisting that has haunted Chinese companies that trade on US exchanges appears to have receded after the US regulators announced they had gained full access to the audits of these companies for the first time.